Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons?
BACKGROUND: The urine lipoarabinomannan (LAM) strip-test (Determine®-TB) can rapidly rule-in TB in HIV-infected persons with advanced immunosuppression. However, given high rates of empiric treatment amongst hospitalised patients in high-burden settings (≈ 50%) it is unclear whether LAM can add any...
Main Authors: | Jonathan G Peter, Grant Theron, Keertan Dheda |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3563660?pdf=render |
Similar Items
-
Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection
by: Phindile Gina, et al.
Published: (2017-05-01) -
The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce.
by: Jonathan G Peter, et al.
Published: (2012-01-01) -
Does the use of adjunct urine lipopolysaccharide lipoarabinomannan in HIV-infected hospitalized patients reduce the utilization of healthcare resources? A post hoc analysis of the LAM multi-country randomized controlled trial
by: Poobalan Naidoo, et al.
Published: (2019-02-01) -
Analysis of the Validity of Urine LAM ELISA for Tuberculosis Infection
by: Zhao Junpeng, et al.
Published: (2024) -
The Diagnostic Value of Urine Lipoarabinomannan (Lam) Antigen in Childhood Tuberculosis
by: Agustin Iskandar, et al.
Published: (2017-03-01)